Catamount Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $8K | Hold |
70
| – | – | ﹤0.01% | 143 |
|
|
2018
Q4 | $8K | Sell |
70
-37,495
| -100% | -$4.29M | 0.01% | 140 |
|
|
2018
Q3 | $4.58M | Sell |
37,565
-75
| -0.2% | -$9.15K | 2.19% | 17 |
|
|
2018
Q2 | $4.39M | Sell |
37,640
-170
| -0.4% | -$19.8K | 2.12% | 16 |
|
|
2018
Q1 | $4.04M | Buy |
37,810
+85
| +0.2% | +$9.07K | 2.15% | 14 |
|
|
2017
Q4 | $4.03M | Sell |
37,725
-720
| -2% | -$76.9K | 2.25% | 14 |
|
|
2017
Q3 | $4.28M | Buy |
38,445
+1,725
| +5% | +$192K | 2.49% | 12 |
|
|
2017
Q2 | $3.8M | Buy |
+36,720
| New | +$3.8M | 2.31% | 16 |
|
|
2015
Q3 | – | Sell |
-111
| Closed | -$14K | – | 170 |
|
|
2015
Q2 | $14K | Sell |
111
-489
| -82% | -$61.7K | 0.01% | 109 |
|
|
2015
Q1 | $69K | Buy |
600
+87
| +17% | +$10K | 0.06% | 52 |
|
|
2014
Q4 | $52K | Buy |
+513
| New | +$52K | 0.05% | 49 |
|